The Lung Precision Oncology Program (LPOP) has the stated mission of improving care for all of our nation’s Veterans that have been diagnosed with lung cancer. In developing this nation-wide LPOP program, the VA has selected locations across the country to serve as central Hub sites, which work together with local VA facilities on screening, genetic testing, and participation in clinical trials. The VA LPOP ensures that Veterans have access to cutting-edge cancer care no matter where they live.
The Miami VAMC is proud to be part of VHA’s Precision Oncology Initiative, aiming to continue to create a system of excellence in oncology care. To accomplish this goal, LPOP has assembled experts in pulmonology, oncology, thoracic surgery, radiation oncology, radiology, pathology and translational sciences here at the Miami VA and around the country to ensure that we can make a difference in the battle against lung cancer. Through timely lung cancer screening programs, smoking cessation education and cutting-edge clinical trials, we are happy to say that we’re closer to that goal than ever.
The program goals include:
- Increasing screening to detect lung cancer sooner in Veterans at risk
- Offering genetic testing for Veterans with lung cancer
- Providing Veterans with lung cancer access to unique, new treatment options and precision oncology trials
- Integrating new knowledge into lung cancer care
While great progress has been made, Veterans need more and better options. Precision oncology means matching the right treatment to the right patient using a molecular understanding of their cancer. Our focus is to provide targeted cancer care for veterans while facilitating access to investigational therapies through clinical trials.
